Board of Directors

Dr. Yaron Daniely

Dr. Daniely serves as the CEO of Yissum since June 2017. Before joining Yissum, he was the President and CEO of Alcobra Ltd. (NASDAQ:ADHD), the President and CEO of NanoCyte, Inc., the General Manager of Gamida Cell—Teva Joint Venture Ltd., and the VP Business Development of Gamida Cell Ltd.
Dr. Daniely has a Ph.D. from the New York University School of Medicine and an Executive M.B.A. from the Technion.

Prof. Isaiah Arkin

Prof. Arkin serves as the Head of the Authority for Research and Development at the Hebrew University of Jerusalem. Prof. Arkin was appointed Chair of the Alexander Silberman Institute of Life Sciences.

Prof. Hermona Soreq

Prof. Soreq is the Charlotte Slesinger Professor of Molecular Neuroscience at The Hebrew University of Jerusalem’s Edmond and Lily Safra Center for Brain Sciences. Previously, Prof. Soreq served as Dean of the Hebrew University’s Faculty of Science.

MR. Erez Mizrachi

Mr. Mizrachi is a Senior Partner at FWMK law firm where he leads the high-tech and venture capital department. Prior to founding FWMK, Mr. Mizrachi worked in the high-tech department of the Zysman, Aharoni & Gayer firm and was a high-tech partner at Mirkin-Efrima & Co.
Mr. Mizrachi has an LL.B. and B.A (Business Management) from the Israeli College of Management.

Ms. Jackie Struminger

Ms. Struminger has over 20 years of experience in finance and capital markets. Until recently, she served as the Head of the Investment Sector at the leading Halman-Aldubi Investment House in Israel. Ms. Struminger holds an MBA and MA in Public Policy from the Tel Aviv University.

Mr. Sharon Cohen

Mr. Cohen has served as CFO for Yissum since 2010. He is a CPA and graduated with a BA in Business Management and Accounting and MBA from the Israeli College of Management.